September 14, 2023
New gene therapy company created and funded by Oxford Science Enterprises, Harrington Discovery Institute and Old College Capital in partnership with six leading scientists from the world-renowned UK Respiratory Gene Therapy Consortium (GTC) AlveoGene initially aims to leverage proprietary lentiviral gene therapy platform...
Continue Reading
October 19, 2022
Grant award provides MD/PhD candidates with funding and expertise to translate promising scientific discoveries into medicines Continue Reading
August 08, 2022
Hope to Help Patients with Retinitis Pigmentosa Continue Reading
August 02, 2022
New therapy seeks to protect from rare muscle-wasting disorder Continue Reading
July 25, 2022
Harrington Discovery Institute and the American Society for Clinical Investigation seek nominations to recognize an outstanding achievement by a physician-scientist Continue Reading
June 13, 2022
Grant programme seeks to advance novel therapies for rare diseases Continue Reading
June 01, 2022
Focus on epigenetics, neurovascular health, and other novel approaches Continue Reading
April 28, 2022
More than 150 drug discovery projects now supported by Harrington Discovery Institute Continue Reading
April 25, 2022
Novel CryptigenTM technology unlocks full potential of Tumour Specific Antigens Continue Reading
March 24, 2022
2022 Harrington Prize for Innovation in Medicine Recognizes Breakthrough Innovations in the Use of Human Antibodies to Treat COVID-19 Continue Reading
February 23, 2022
February 23, 2022, CLEVELAND, Ohio USA - Harrington Discovery Institute at University Hospitals is now accepting the Letters of Intent for the 2023 Harrington Scholar-Innovator Award for physician-scientists. The award offers successful applicants financial resources and expertise to advance their discoveries toward clinical... Continue Reading